Refine by
Adiso Tissue Damage Equipment & Supplies
1 equipment items found
Manufactured by:Adiso Therapeutics based inConcord, MASSACHUSETTS (USA)
ADS051 blocks MRP2 release of HXA3 gradient, while also blocking FPR1 activation of neutrophils within the colonic epithelium. Unlike currently available therapies, this addresses neutrophil-mediated tissue damage, a hallmark of UC pathology. In a healthy volunteer study, ADS051 was safe and well-tolerated and restricted to the gut with limited systemic ...